Literature DB >> 29288291

Transfusion of Blood Products in the Neurocritical Care Unit: An Exploration of Rationing and Futility.

Deepa P Malaiyandi1, Galen V Henderson2, Michael A Rubin3.   

Abstract

Rationing is the allocation of scarce resources, which in healthcare necessarily requires withholding potentially beneficial treatments from some individuals. While it often entails a negative connotation, rationing is unavoidable because need is limitless and resources are not. How rationing occurs is important, because it not only affects individual lives, but also reflects society's most important values. At the core of any rationing, decision is how much a limited resource may benefit a patient, which can be particularly difficult to determine in the practice of neurocritical care, as prognosis is often uncertain. We present a case for the consideration of futility and blood product rationing in neurocritical care.

Entities:  

Keywords:  Blood transfusion; Conflict resolution; Ethics; Futility; Neurological prognostication; Rationing

Mesh:

Year:  2018        PMID: 29288291     DOI: 10.1007/s12028-017-0478-4

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  10 in total

1.  The sequence of withdrawing life-sustaining treatment from patients.

Authors:  D A Asch; K Faber-Langendoen; J A Shea; N A Christakis
Journal:  Am J Med       Date:  1999-08       Impact factor: 4.965

Review 2.  Rationing critical care beds: a systematic review.

Authors:  Tasnim Sinuff; Kamayar Kahnamoui; Deborah J Cook; John M Luce; Mitchell M Levy
Journal:  Crit Care Med       Date:  2004-07       Impact factor: 7.598

Review 3.  How do I allocate blood products at the end of life? An ethical analysis with suggested guidelines.

Authors:  Lauren B Smith; Laura Cooling; Robertson Davenport
Journal:  Transfusion       Date:  2012-04-23       Impact factor: 3.157

4.  Perceptions of cost constraints, resource limitations, and rationing in United States intensive care units: results of a national survey.

Authors:  Nicholas S Ward; Joan M Teno; J Randall Curtis; Gordon D Rubenfeld; Mitchell M Levy
Journal:  Crit Care Med       Date:  2008-02       Impact factor: 7.598

5.  An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units.

Authors:  Gabriel T Bosslet; Thaddeus M Pope; Gordon D Rubenfeld; Bernard Lo; Robert D Truog; Cynda H Rushton; J Randall Curtis; Dee W Ford; Molly Osborne; Cheryl Misak; David H Au; Elie Azoulay; Baruch Brody; Brenda G Fahy; Jesse B Hall; Jozef Kesecioglu; Alexander A Kon; Kathleen O Lindell; Douglas B White
Journal:  Am J Respir Crit Care Med       Date:  2015-06-01       Impact factor: 21.405

6.  Should blood be an essential medicine?

Authors:  Harvey G Klein
Journal:  N Engl J Med       Date:  2013-01-17       Impact factor: 91.245

Review 7.  Traumatic brain injury-associated coagulopathy.

Authors:  Jianning Zhang; Rongcai Jiang; Li Liu; Timothy Watkins; Fangyi Zhang; Jing-fei Dong
Journal:  J Neurotrauma       Date:  2012-10-31       Impact factor: 5.269

Review 8.  Burnout syndrome among critical care healthcare workers.

Authors:  Nathalie Embriaco; Laurent Papazian; Nancy Kentish-Barnes; Frederic Pochard; Elie Azoulay
Journal:  Curr Opin Crit Care       Date:  2007-10       Impact factor: 3.687

9.  Patient-related factors and circumstances surrounding decisions to forego life-sustaining treatment, including intensive care unit admission refusal.

Authors:  Jean Reignier; Romain Dumont; Sandrine Katsahian; Laurent Martin-Lefevre; Benoit Renard; Maud Fiancette; Christine Lebert; Eva Clementi; Frederic Bontemps
Journal:  Crit Care Med       Date:  2008-07       Impact factor: 7.598

10.  Reasons for refusal of admission to intensive care and impact on mortality.

Authors:  Gaetano Iapichino; Davide Corbella; Cosetta Minelli; Gary H Mills; Antonio Artigas; David L Edbooke; Angelo Pezzi; Jozef Kesecioglu; Nicolò Patroniti; Mario Baras; Charles L Sprung
Journal:  Intensive Care Med       Date:  2010-06-09       Impact factor: 17.440

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.